Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,236 results that match your search.22,236 results
  • Last month, Japan introduced sound, motion, colour per se, holograms and position marks. Kensaku Takase and Mariko Nakayama investigate who will be using them, and what benefits they provide
  • More than 1,000 new gTLDs are set to go live within the next few years, with many already launched. Trade mark owners need to reevaluate enforcement in this new internet ecosystem, argue Brian Winterfeldt and Griffin M Barnett
  • The Federal Circuit saying squashing words together in briefs is not a way to keep below word limits, Canada intending to increase the term of copyright, Katy Perry’s attempts to register trade marks, John Oliver’s take on patent trolls, and Twitter’s trade mark applications were in the IP headlines this week
  • China’s newest draft revision to the Patent Law brings a raft of changes, including provisions to encourage patent licensing as well as strengthen design patent protection
  • Christoph Rieken will join law firm Noerr on May 1. He was formerly head of the German IP practice at Ashurst
  • The Federal Circuit affirmed the USPTO’s rejection of an application for the The Slants mark on the grounds that the term was disparaging to Asians. After drafting the court’s opinion, Judge Kimberly Moore penned an “additional views” section questioning the constitutionality of Section 2(a) of the Lanham Act
  • The so-called trilogue comprising the European Parliament, Commission and Council have agreed a deal on EU trade mark reform. But with details still sketchy, Managing IP analyses what is clear and what is still to be revealed
  • Finally, after five years of debate, there is an agreement on reform to the EU Trade Marks Directive and CTM Regulation. While there is a cautious welcome for what has been agreed, we are likely to enter a new period of adaptation and scrutiny
  • The Coalition for Affordable Drugs has filed another inter partes review petition at the Patent Trial and Appeal Board, in the latest move by Kyle Bass and Erich Spangenberg to target pharmaceutical companies’ patents
  • In Argentina, legislation that regulates the protection of test data (Law 24,766 Confidentiality Law, Executive Order 150/92) does not provide adequate test data protection to pharmaceutical specialities as required in Section 39.3 of the TRIPs Agreement, because it allows third-party reliance on information concerning the safety and efficacy of a product – reliance that is not authorised by the originator of the data.